JOURNAL OF DRUG TARGETING
ISSN:1061-186X

JOURNAL OF DRUG TARGETING

J DRUG TARGET
学科领域:医学
是否预警:不在预警名单内
是否OA:
录用周期:平均2月
新锐分区:医学3区
年发文量:124
影响因子:3.9
JCR分区:Q1

基本信息

药物靶向杂志发表论文和评论的所有方面的药物输送和靶向分子和大分子药物,包括载体系统的设计和表征(无论是胶体的、蛋白质的还是聚合物的)用于这些药物的体外和/或体内应用。还包括对设计成靶向特定细胞或细胞外分子的分子和大分子药物的研究。因此,该杂志发表了关于治疗性肽/蛋白质和核酸的活性、递送和靶向的结果,包括基因/质粒DNA、基因沉默核酸(例如小干扰(si)RNA、反义寡核苷酸、核酶、DNA酶)以及适体、单核苷酸和单克隆抗体及其缀合物。靶向技术的诊断应用以及诊断和成像剂的靶向递送也属于该杂志的范围。此外,还寻求关于自我调节系统、对环境和外部刺激作出反应的系统以及能够产生程序化、脉冲化和其他复杂输送模式的系统的论文。
1061-186XSCIE/Scopus收录
3.9
4.7
2026年3月发布
点击查看历史分区趋势    >
大类学科小类学科Top期刊综述期刊
医学3区
PHARMACOLOGY & PHARMACY 药学
3区
N/A
WOS期刊SCI分区  2024-2025最新升级版
按JIF指标学科分区收集子录JIF分区JIF排名百分位
学科:PHARMACOLOGY & PHARMACY
SCIE
Q1
88/352
按JCR指标学科分区收集子录JCR分区JCR排名百分位
学科:PHARMACOLOGY & PHARMACY
SCIE
Q2
93/353
80
124
32%0平均2月-医学-药学
2.6%
时间预警情况
2026年03月发布的新锐学术版不在预警名单中
2025年03月发布的2025版不在预警名单中
2024年02月发布的2024版不在预警名单中
2023年01月发布的2023版不在预警名单中
2021年12月发布的2021版不在预警名单中
2020年12月发布的2020版不在预警名单中
40.32%2.22%-
CiteScore:8.90
SJR:0.870
SNIP:0.709
学科类别分区排名百分位
大类:Pharmacology, Toxicology and Pharmaceutics
小类:Pharmaceutical Science
Q1
27 / 185

期刊高被引文献

RGD peptide-based non-viral gene delivery vectors targeting integrin αvβ3 for cancer therapy
来源期刊:Journal of Drug TargetingDOI:10.1080/1061186X.2018.1455841
Liposome: composition, characterisation, preparation, and recent innovation in clinical applications
来源期刊:Journal of Drug TargetingDOI:10.1080/1061186X.2018.1527337
Targeted cancer drug delivery with aptamer-functionalized polymeric nanoparticles
来源期刊:Journal of Drug TargetingDOI:10.1080/1061186X.2018.1491978
MicroRNA-497-5p down-regulation increases PD-L1 expression in clear cell renal cell carcinoma
来源期刊:Journal of Drug TargetingDOI:10.1080/1061186X.2018.1479755
Investigation on the effect of nanoparticle size on the blood–brain tumour barrier permeability by in situ perfusion via internal carotid artery in mice
来源期刊:Journal of Drug TargetingDOI:10.1080/1061186X.2018.1497037
Targeting pulmonary tuberculosis using nanocarrier-based dry powder inhalation: current status and futuristic need
来源期刊:Journal of Drug TargetingDOI:10.1080/1061186X.2018.1455842
Overexpression of HOXC10 promotes glioblastoma cell progression to a poor prognosis via the PI3K/AKT signalling pathway
来源期刊:Journal of Drug TargetingDOI:10.1080/1061186X.2018.1473408
The effect of transferrin-targeted, resveratrol-loaded liposomes on neurosphere cultures of glioblastoma: implications for targeting tumour-initiating cells
来源期刊:Journal of Drug TargetingDOI:10.1080/1061186X.2018.1550647
Mechanisms of the effectiveness of lipid nanoparticle formulations loaded with anti-tubercular drugs combinations toward overcoming drug bioavailability in tuberculosis
来源期刊:Journal of Drug TargetingDOI:10.1080/1061186X.2019.1613409
Knockdown of lncRNA BLACAT1 reverses the resistance of afatinib to non-small cell lung cancer via modulating STAT3 signalling
来源期刊:Journal of Drug TargetingDOI:10.1080/1061186X.2019.1650368
LOX/LOXL in pulmonary fibrosis: potential therapeutic targets
来源期刊:Journal of Drug TargetingDOI:10.1080/1061186X.2018.1550649
Hydrogen sulphide promotes osteoclastogenesis by inhibiting autophagy through the PI3K/AKT/mTOR pathway
来源期刊:Journal of Drug TargetingDOI:10.1080/1061186X.2019.1624969
Anti-miRNA21 and resveratrol-loaded polysaccharide-based mesoporous silica nanoparticle for synergistic activity in gastric carcinoma
来源期刊:Journal of Drug TargetingDOI:10.1080/1061186X.2019.1610766
Liposome–ligand conjugates: a review on the current state of art
来源期刊:Journal of Drug TargetingDOI:10.1080/1061186X.2019.1648479
Artemisinin alleviates atherosclerotic lesion by reducing macrophage inflammation via regulation of AMPK/NF-κB/NLRP3 inflammasomes pathway
来源期刊:Journal of Drug TargetingDOI:10.1080/1061186X.2019.1616296
Mesoporous silica-coated gold nanostars with drug payload for combined chemo-photothermal cancer therapy
来源期刊:Journal of Drug TargetingDOI:10.1080/1061186X.2018.1499746
Redox-responsive smart nanogels for intracellular targeting of therapeutic agents: applications and recent advances
来源期刊:Journal of Drug TargetingDOI:10.1080/1061186X.2018.1514041
The role of mitochondrial defects and oxidative stress in Alzheimer’s disease
来源期刊:Journal of Drug TargetingDOI:10.1080/1061186X.2019.1584808
A mitochondrion-targeting tanshinone IIA derivative attenuates myocardial hypoxia reoxygenation injury through a SDH-dependent antioxidant mechanism
来源期刊:Journal of Drug TargetingDOI:10.1080/1061186X.2019.1566338
SAHA (vorinostat) facilitates functional polymer-based gene transfection via upregulation of ROS and synergizes with TRAIL gene delivery for cancer therapy
来源期刊:Journal of Drug TargetingDOI:10.1080/1061186X.2018.1519028
Phage-displayed peptides targeting specific tissues and organs
来源期刊:Journal of Drug TargetingDOI:10.1080/1061186X.2018.1531419
Targeted delivery of doxorubicin by magnetic mesoporous silica nanoparticles armed with mucin-1 aptamer
来源期刊:Journal of Drug TargetingDOI:10.1080/1061186X.2019.1616745
Targeting triple negative breast cancer heterogeneity with chalcones: a molecular insight
来源期刊:Journal of Drug TargetingDOI:10.1080/1061186X.2018.1561889
LPS-induced inflammation delays the transportation of ASP+ due to down-regulation of OCTN1/2 in alveolar epithelial cells
来源期刊:Journal of Drug TargetingDOI:10.1080/1061186X.2019.1678169
Poly(ethylene glycol)-alendronate coated nanoparticles for magnetic resonance imaging of lymph nodes
来源期刊:Journal of Drug TargetingDOI:10.1080/1061186X.2018.1545235
Mycobacterium tuberculosis metC (Rv3340) derived hydrogen sulphide conferring bacteria stress survival
来源期刊:Journal of Drug TargetingDOI:10.1080/1061186X.2019.1579820
Serpina3n: Potential drug and challenges, mini review
来源期刊:Journal of Drug TargetingDOI:10.1080/1061186X.2019.1693576
Anti-inflammatory flurbiprofen nasal powders for nose-to-brain delivery in Alzheimer’s disease
来源期刊:Journal of Drug TargetingDOI:10.1080/1061186X.2019.1574300
Targeting central nervous system pathologies with nanomedicines
来源期刊:Journal of Drug TargetingDOI:10.1080/1061186X.2018.1533556
MDM2 antagonist-loaded targeted micelles in combination with doxorubicin: effective synergism against human glioblastoma via p53 re-activation
来源期刊:Journal of Drug TargetingDOI:10.1080/1061186X.2019.1570518
SLFN11 is a general target for enhancing the sensitivity of cancer to chemotherapy (DNA-damaging agents)
来源期刊:Journal of Drug TargetingDOI:10.1080/1061186X.2019.1616746
Activation of Kv7 channels with the anticonvulsant retigabine alleviates neuropathic pain behaviour in the streptozotocin rat model of diabetic neuropathy
来源期刊:Journal of Drug TargetingDOI:10.1080/1061186X.2019.1608552
Autophagy: a killer or guardian of vascular smooth muscle cells
来源期刊:Journal of Drug TargetingDOI:10.1080/1061186X.2019.1705312
Polymeric nanodroplets: an emerging trend in gaseous delivery system
来源期刊:Journal of Drug TargetingDOI:10.1080/1061186X.2019.1588281
Nrf2-mediated cytoprotective effect of four different hyaluronic acids by molecular weight in human tenocytes
来源期刊:Journal of Drug TargetingDOI:10.1080/1061186X.2019.1648476
Drug-free macromolecular therapeutics exhibit amplified apoptosis in G2/M phase arrested cells
来源期刊:Journal of Drug TargetingDOI:10.1080/1061186X.2018.1521414
Raloxifene nano-micelles effect on triple-negative breast cancer is mediated through estrogen receptor-β and epidermal growth factor receptor
来源期刊:Journal of Drug TargetingDOI:10.1080/1061186X.2019.1566341
HIF1α-siRNA and gemcitabine combination-based GE-11 peptide antibody-targeted nanomedicine for enhanced therapeutic efficacy in pancreatic cancers
来源期刊:Journal of Drug TargetingDOI:10.1080/1061186X.2018.1552276
Low-intensity light-induced drug release from a dual delivery system comprising of a drug loaded liposome and a photosensitive conjugate
来源期刊:Journal of Drug TargetingDOI:10.1080/1061186X.2019.1710838
Development of ERK1/2 inhibitors as a therapeutic strategy for tumour with MAPK upstream target mutations
来源期刊:Journal of Drug TargetingDOI:10.1080/1061186X.2019.1648477
Potential use of aptamers for diagnosis and treatment of pancreatic cancer
来源期刊:Journal of Drug TargetingDOI:10.1080/1061186X.2018.1564924
Quercetin inhibits human microvascular endothelial cells viability, migration and tube-formation in vitro through restraining microRNA-216a
来源期刊:Journal of Drug TargetingDOI:10.1080/1061186X.2019.1700263
Sulpiride gastro-retentive floating microsponges; analytical study, in vitro optimization and in vivo characterization
来源期刊:Journal of Drug TargetingDOI:10.1080/1061186X.2019.1663526
Photodynamic therapy on skin melanoma and epidermoid carcinoma cells using conjugated 5-aminolevulinic acid with microbial synthesised silver nanoparticles
来源期刊:Journal of Drug TargetingDOI:10.1080/1061186X.2018.1531418
Free radical-mediated targeting and immobilization of coupled payloads
来源期刊:Journal of Drug TargetingDOI:10.1080/1061186X.2019.1584807
Targeted silencing of genes related to acute monocytic leukaemia by CpG(B)-MLAA-34 siRNA conjugates
来源期刊:Journal of Drug TargetingDOI:10.1080/1061186X.2019.1689397
Pyrrole derivatives as potential anti-cancer therapeutics: synthesis, mechanisms of action, safety
来源期刊:Journal of Drug TargetingDOI:10.1080/1061186X.2019.1703189
Antimicrobial lipids in nano-carriers for antibacterial delivery
来源期刊:Journal of Drug TargetingDOI:10.1080/1061186X.2019.1681434
Apocynin protects retina cells from ultraviolet radiation damage via inducing sirtuin 1
来源期刊:Journal of Drug TargetingDOI:10.1080/1061186X.2019.1663527
A tribute to Professor Patrick Couvreur: a creative and visionary scientist in the field of nanomedicine
来源期刊:Journal of Drug TargetingDOI:10.1080/1061186X.2019.1579821

相关文章

2026年3月发布
大类学科小类学科Top期刊综述期刊
医学3区
PHARMACOLOGY & PHARMACY 药学
3区
N/A
2025年3月升级版
大类学科小类学科Top期刊综述期刊
医学4区
PHARMACOLOGY & PHARMACY 药学
4区
2023年12月旧的升级版
大类学科小类学科Top期刊综述期刊
医学4区
PHARMACOLOGY & PHARMACY 药学
4区